Fluticasone: all 234 studies that test it

Page 2 of 3. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol TrialCompletedNCT00156819Phase 4Results posted
• A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or ExerciseCompletedNCT00118716Phase 4Results posted
• Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic DermatitisCompletedNCT07537751Not applicable
• INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATIONActive, not recruitingNCT07415278Phase 4
• Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldCompletedNCT06290102Phase 1
• Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal SprayCompletedNCT06180083Phase 1
• Bioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy VolunteersActive, not recruitingNCT05982990Phase 1
• Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy VolunteersStatus unknownNCT05697003Phase 1
• Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With AsthmaStatus unknownNCT05664061Phase 3
• Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive, not recruitingNCT05535738Phase 2/3
• A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT05397834Phase 1
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic ConjunctivitisCompletedNCT05314621Phase 4
• Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy VolunteersStatus unknownNCT05085587Phase 1
• FLuticasone in cOvid Treatment (FLOT)Status unknownNCT05054322Phase 2/3
• A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT05021887Phase 1
• A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy VolunteersStatus unknownNCT04746040Phase 1
• A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With AsthmaCompletedNCT04665895Phase 3
• Allergic Rhinitis Combination Pharmacotherapy Efficacy StudyWithdrawnNCT04601324Phase 4
• A Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy VolunteersCompletedNCT04564456Phase 1
• A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy VolunteersCompletedNCT04546256Phase 1
• A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy VolunteersCompletedNCT04466176Phase 1
• A Pilot Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy VolunteersCompletedNCT04462822Phase 1
• Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPereneCompletedNCT04332978Phase 3
• The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory PhenotypeActive, not recruitingNCT04171167Not applicable
• Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High AltitudeCompletedNCT04111263Not applicable
• A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy VolunteersCompletedNCT03975166Phase 1
• A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)CompletedNCT03894280Phase 1
• A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy VolunteersCompletedNCT03820180Phase 1
• A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy VolunteersCompletedNCT03751202Phase 1
• OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal PolypsCompletedNCT03747458Phase 3
• Seal, Stopping Eczema and Allergy StudyActive, not recruitingNCT03742414Phase 2
• A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With AsthmaCompletedNCT03676413Phase 3
• The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case SeriesCompletedNCT03594565Early Phase 1
• Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)CompletedNCT03535870Not applicable
• A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen ExposureCompletedNCT03443843Phase 4
• Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 YearsStatus unknownNCT03387241Phase 3
• The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in ChildrenTerminatedNCT03040596Phase 1
• MP-AzeFlu Allergen Chamber - Onset of Action StudyCompletedNCT03004131Phase 4
• Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD TherapeuticsActive, not recruitingNCT03002389Phase 2
• A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung MicrobiotaStatus unknownNCT02833480Phase 2
• A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With AsthmaCompletedNCT02680561Phase 1
• Changes in the Lung Clearance Index in Pediatric Patients With AsthmaStatus unknownNCT02678949Not applicable
• Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol XinafoateCompletedNCT02649478Not applicable
• Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled AsthmaCompletedNCT02577497Phase 4
• Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMAStatus unknownNCT02546349Phase 4
• Nebulized Corticosteroid for Post Extubation Stridor in ChildrenCompletedNCT02523820Phase 3
• Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in AsthmaticsWithdrawnNCT02496715Phase 3
• Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/SalmeterolTerminatedNCT02491970Phase 4
• A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy VolunteersActive, not recruitingNCT02476825Phase 4
• Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal BlockCompletedNCT02466503Phase 1
• Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal BlockCompletedNCT02466347Phase 1
• Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and OlderCompletedNCT02437604Phase 1
• Fractional Laser in Combination With UVB Therapy in Vitiligo PatientsWithdrawnNCT02290717Not applicable
• Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™Status unknownNCT02249663Phase 3
• AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)Status unknownNCT02238353Phase 4
• Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIsCompletedNCT02215122Phase 1
• Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPDCompletedNCT02209974Phase 4
• Dietetic Versus Topical Steroids for Pediatric Eosinophilic EsophagitisCompletedNCT01846962Phase 4
• Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in ChildrenTerminatedNCT01772056Phase 3
• Effects of QVAR in Smokers With AsthmaCompletedNCT01741285Phase 4
• Dose-ranging StudyCompletedNCT01712451Phase 2
• Eosinophilic Esophagitis Treatment: Montelukast vs FluticasoneWithdrawnNCT01702701Phase 3
• Phase I Pharmacokinetic Study (SALBLOCK)CompletedNCT01564199Phase 1
• A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/SalmeterolCompletedNCT01540708Phase 1
• Management of Asthma in School-age Children on TherapyCompletedNCT01526161Phase 4
• A 12-Week Study in Adult Subjects With AsthmaCompletedNCT01516086Phase 2
• 12-Week Study in Adult Subjects With AsthmaCompletedNCT01516073Phase 2
• Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric PatientsCompletedNCT01511367Phase 3
• Suitability of a Low Dose Lipopolysaccharide (LPS) Inhalation as a Challenge ModelCompletedNCT01400568Not applicable
• A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In VolunteersCompletedNCT01364519Phase 1
• The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPDStatus unknownNCT01243788Phase 4
• Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*CompletedNCT01240889Not applicable
• Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPDWithdrawnNCT01209715Phase 2
• A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with AsthmaCompletedNCT01202097Phase 3
• A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma PatientsCompletedNCT01202084Phase 3
• Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal SpraysCompletedNCT01194622Phase 1
• Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal SpraysCompletedNCT01190852Phase 1
• A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01168310Phase 2
• A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.CompletedNCT01064726Phase 1
• Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate AsthmaCompletedNCT00995800Phase 2
• Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate AsthmaCompletedNCT00995657Phase 4
• Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of AsthmaCompletedNCT00980707Phase 4
• Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in SmokersCompletedNCT00908362Phase 1
• Steroid Sparing Effect of Nasal Corticosteroid In Asthma And RhinitisCompletedNCT00903227Phase 4
• Study of Biomarkers of Airway Inflammation (0000-128)CompletedNCT00869596Phase 1
• Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in KoreaCompletedNCT00864812Phase 4
• Azelastine Fluticasone Combination vs. FluticasoneWithdrawnNCT00845598Phase 4
• Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate AsthmaCompletedNCT00830505Phase 4
• Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma PatientsCompletedNCT00830102Phase 2
• Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)CompletedNCT00817050Phase 4
• Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)CompletedNCT00783458Phase 4
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00774761Phase 2
• Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgECompletedNCT00755066Not applicable
• Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in AsthmaCompletedNCT00736801Not applicable
• Repeated High-dose Inhaled Corticosteroids for AsthmaWithdrawnNCT00695604Phase 2
• A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy VolunteersCompletedNCT00674050Phase 1
• A Comparison of Olopatadine and Fluticasone in Patients With Allergic ConjunctivitisCompletedNCT00655109Phase 4
• A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT00612820Phase 2
• Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in AsthmaCompletedNCT00606242Phase 4
• Leukotriene Receptor Antagonists or Steroids in Pre-School AsthmaCompletedNCT00543686Phase 2

← Fluticasone overview